Evidence map›Paper›PMID 40033028›Full record

ArticleOncogene2025

Correction: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Prahlad V Raninga, Bijun Zeng, Davide Moi, Ethan Trethowan, Federica Saletta, Pooja Venkat, Chelsea Mayoh, Rochelle C J D'Souza, Bryan W Day, Tyler Shai-Hee and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncogene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Prahlad V RaningaQIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia. Prahlad.Raninga@mater.uq.edu.au.ORCID http://orcid.org/0000-0003-3013-6526
Bijun ZengPeter McCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Davide MoiPeter McCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Ethan TrethowanPeter McCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Federica SalettaChildren's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.
Pooja VenkatChildren's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.
Chelsea MayohChildren's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.ORCID http://orcid.org/0000-0002-6398-3046
Rochelle C J D'SouzaQIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia.
Bryan W DayQIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia.
Tyler Shai-HeeChildren's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.
Orazio VittorioChildren's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, NSW, Australia.
Roberta Mazzieri *Peter McCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Riccardo Dolcetti *Peter McCallum Cancer Centre, 305 Grattan Street, Melbourne, VIC, 3000, Australia.
Kum Kum Khanna *QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, QLD, 4006, Australia. KumKum.Khanna@mater.edu.edu.au.ORCID http://orcid.org/0000-0001-8650-5381

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40033028
PMCPMC11932919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.